---ATTEND IN PERSON--- New drug development is a huge endeavor that can take 15 years, cost > $2B and still have a 80 – 90% failure rate. Now new applications of AI may streamline this process by predictive modeling that increases drug safety, decreases development cost and time to market, and improves overall patient outcomes.
When
Thursday, August 25, 2022 from 11:30 AM to 1:00 PM CDTLook who else is already registered!
| Stephen Amerson The Institute for Extracorporeal Life Support , Research Coordinator |
| Jennifer Aquino PNC , RM |
| Chris Armijo |
| Jolyn Bragg UT Health San Antonio , Marketing Director |
| Roger Burg O'Malley Burg Consulting , President |
| Hani El Shawa Caris Life Science , Area Vice President Molecular Life Science |
| Scott Farmer WellMed , Director, Connected Care |
| Patricia Geppert JBSA 5GPMO , JBSA 5GPMO |
| Monica Hayes Fusion Success Group , Managing Principal |
| Mary Jimenez Caris , VP, Strategic Account Management |
| Robert Johnson SMA Inc. , Executive Advisor |
| Sumita Jonak NurLabs , Founder |
| Madelon Leone CapTrust Financial Advisors , CapTrust Financial Advisors |
| Muayad Maallah Thompson Consulting |
| Gennaro Maida betweenMD, inc , betweenMD, inc |
| Rick Morris GaitIQ, Inc. , GaitIQ, Inc. |
| Jeremy Nelson DHA , Scientist |
| Darian Padua MAVERICK MRI , CEO |
| Abraham Padua Armrit Maverick MRI , Cofounder/CTO |
| Micki Philbin Boston Scientific , Peripheral Vascular Comsultant |
| Jim Reed San Antonio Medical Foundation , President |
| Jason Scharf Austin Next , Investor and Podcast Host |
| Kay Scroggins Flourish Research-Clinical Trials of Texas, LLC , Board Member (Former President/CEO. Now retired) |
| Kristy Sigman PNC , RM |
| Linda Sousse Institute for Extracorporeal Life Support , Director of Research |
| David Tapia Exegete Healthcare International, LLC , Managing Partner |
| Anne Thompson Air Force Research Laboratory , Executive Consultant |
| Meredith Zozus UTHSCSA |